The Central drug regulator, DCGA has approved emergency use authorisation of the Russian Vaccine, Sputnik V. It has now become the third vaccine to get emergency use authorisation from the drug regulator after Covishield and Covaxin. The Vaccine was developed by Gamaleya National Research Institute of Epidemiology and Microbiology last year in Russia.
About Sputnik V clinical trial:
Important takeaways for all competitive exams:
The Anant Anadi Vadnagar Archaeological Experiential Museum, located in Vadnagar, Mehsana district, Gujarat, has won…
India, the United States and eight other countries signed the San Francisco Declaration on the…
Pakistan has secured Geographical Indication (GI) recognition for Basmati rice in Türkiye, marking an important…
France awarded the prestigious Legion of Honour (Légion d'honneur) to William F. Lyford, a 102-year-old…
The National Payments Corporation of India (NPCI) introduced the UPI Vyapaar Saksham Scheme through a…
The International Cricket Council (ICC) officially announced the unopposed reappointment of Jay Shah as its…